Antiviral Lipid Nanocarrier Loaded with Remdesivir Effective Against SARS-CoV-2 in vitro Model

INTRODUCTION: The ongoing SARS-CoV-2 pandemic has affected public health, the economy, and society. This study reported a nanotechnology-based strategy to enhance the antiviral efficacy of the antiviral agent remdesivir (RDS). RESULTS: We developed a nanosized spherical RDS-NLC in which the RDS was...

Descripción completa

Detalles Bibliográficos
Autores principales: Jeon, Woo-Jin, Lee, Hong-Ki, Na, Young-Guk, Jung, Minwoo, Han, Su-Cheol, Hwang, Jeong Ho, Jung, Eunhye, Hwang, Dasom, Shin, Jin Soo, Cho, Cheong-Weon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10065008/
https://www.ncbi.nlm.nih.gov/pubmed/37007987
http://dx.doi.org/10.2147/IJN.S391462

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10065008/
https://www.ncbi.nlm.nih.gov/pubmed/37007987
http://dx.doi.org/10.2147/IJN.S391462

Ejemplares similares